Reducing Door-To-Antibiotic Time in Community-Acquired Pneumonia: Controlled Before-And-After Evaluation and Cost-Effectiveness Analysis

Thorax - United Kingdom
doi 10.1136/thx.2005.056689
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Low Procalcitonin, Community Acquired Pneumonia, and Antibiotic Therapy

The Lancet Infectious Diseases
Infectious Diseases
2018English

Door-To-Antibiotic Time for Pneumonia in a Rural Emergency Department

Canadian Journal of Emergency Medicine
Emergency Medicine
2010English

Corticosteroids for Community-Acquired Pneumonia: Time to Act!

Critical Care
Critical CareIntensive Care Medicine
2008English

Effectiveness of Discontinuing Antibiotic Treatment After Three Days Versus Eight Days in Mild to Moderate-Severe Community Acquired Pneumonia: Randomised, Double Blind Study

BMJ
2006English

Antibiotic Use for Community-Acquired Pneumonia in Neonates and Children: WHO Evidence Review

Paediatrics and international child health
Child HealthPediatricsPerinatology
2018English

Platelets and Community Acquired Pneumonia

Clinical Epidemiology and Global Health
EpidemiologyPublic HealthMicrobiologyEnvironmentalInfectious DiseasesOccupational Health
2018English

Time to Clinical Stability in Patients Hospitalized With Community-Acquired Pneumonia

JAMA - Journal of the American Medical Association
Medicine
1998English

Initial Empiric Antibiotic Therapy for Community-Acquired Pneumonia in Chinese Hospitals

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2018English

Community-Acquired Pneumonia

2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy